These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6200026)

  • 21. Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.
    Brenner T; Beyth Y; Abramsky O
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3635-9. PubMed ID: 6158053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits.
    Levi G; Tarrab-Hazdai R; Teichberg VI
    Eur J Immunol; 1983 Jun; 13(6):500-7. PubMed ID: 6861875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic mechanisms in neurologic diseases.
    Armstrong RM
    Med Clin North Am; 1972 Mar; 56(2):515-27. PubMed ID: 4553196
    [No Abstract]   [Full Text] [Related]  

  • 25. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
    Teitelbaum D; Webb C; Arnon R; Sela M
    Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental autoimmune myasthenia gravis.
    Lindstrom J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):568-76. PubMed ID: 6249892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental myasthenia gravis.
    Goldstein G; Hofmann WW
    Res Publ Assoc Res Nerv Ment Dis; 1971; 49():241-59. PubMed ID: 4329690
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX; Ma CG; Xiao BG; Bakhiet M; Link H; Olsson T
    Eur J Immunol; 1995 May; 25(5):1191-8. PubMed ID: 7774622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoimmune diseases.
    Rose NR
    Sci Am; 1981 Feb; 244(2):80-4, 86, 90 passim. PubMed ID: 6163209
    [No Abstract]   [Full Text] [Related]  

  • 32. Autoimmune reactions against myelin basic protein induced by corona and measles viruses.
    ter Meulen V
    Ann N Y Acad Sci; 1988; 540(1):202-9. PubMed ID: 2462802
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimmunologic disease: experimental and clinical aspects.
    Paterson PY; Day ED
    Hosp Pract; 1979 Jul; 14(7):49-58. PubMed ID: 90005
    [No Abstract]   [Full Text] [Related]  

  • 35. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Spaans F; De Baets MH
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the pathophysiology of chronic D-penicillamine-induced myasthenia.
    Burres SA; Kanter ME; Richman DP; Arnason BG
    Ann N Y Acad Sci; 1981; 377():640-51. PubMed ID: 6951489
    [No Abstract]   [Full Text] [Related]  

  • 37. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral tolerance in myasthenia gravis.
    Drachman DB; Okumura S; Adams RN; McIntosh KR
    Ann N Y Acad Sci; 1996 Feb; 778():258-72. PubMed ID: 8610979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myasthenia gravis and acetylcholine receptor].
    Abramsky O; Aharonov A; Tarrab-Hazdai R; Fuchs S
    Harefuah; 1975 Dec; 89(12):553-6. PubMed ID: 815144
    [No Abstract]   [Full Text] [Related]  

  • 40. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.